Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: report of a case.
We report a 67-year-old male with pneumonia in which Chlamydia pneumoniae was identified by serologic studies as the causative agent. After initial treatment failure with amoxicillin + clavulanic acid, pneumonia was successfully treated with the administration of oral azithromycin, 500 mg per day, for three days. Azithromycin is a new macrolide which has a long half-life and superior action to erythromycin. It provides a new and alternative choice in the treatment of Chlamydia pneumoniae infection in the future.
Wang
J H
JH
Department of Internal Medicine, Veterans General Hospital, Kaohsiung, Taiwan R.O.C.
Wang
J H
JH
Liu
Y C
YC
Chen
Y S
YS
Yen
M Y
MY
Wann
S R
SR
Cheng
D L
DL
D000368:Aged; D017963:Azithromycin / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy*; D016993:Chlamydophila pneumoniae; D006801:Humans; D008297:Male; D018410:Pneumonia, Bacterial / Q000188:drug therapy*
D017963:Azithromycin